Lobbying client

VAXXINITY, INC.

Biotechnology company

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
12
Filed by
2
Reported in-house
—
Reported by firms
$480,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2021 to 2022

Filings

6 filings for 2022, newest first.
Filing Filed by Amount
4th Quarter - Termination
4th Quarter 2022
BUCHANAN INGERSOLL & ROONEY PC $50,000 reported
3rd Quarter - Report
3rd Quarter 2022
BUCHANAN INGERSOLL & ROONEY PC $50,000 reported
2nd Quarter - Amendment
2nd Quarter 2022
BUCHANAN INGERSOLL & ROONEY PC $50,000 reported
2nd Quarter - Reportreplaced
2nd Quarter 2022
BUCHANAN INGERSOLL & ROONEY PC $20,000 reported
1st Quarter - Report
1st Quarter 2022
BUCHANAN INGERSOLL & ROONEY PC $20,000 reported
Registration
1st Quarter 2022
BUCHANAN INGERSOLL & ROONEY PC — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
MICHAEL BEST STRATEGIES LLC 4 $310,000
BUCHANAN INGERSOLL & ROONEY PC 4 $170,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 9
Aerospace AER 4
Manufacturing MAN 4
Medical/Disease Research/Clinical Labs MED 4
Defense DEF 4
Veterans VET 4

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.